Laboratorio Reig Jofre S.A.
Research Laboratorio Reig Jofre S.A. (0RB1) on Bullrun: P/E 40.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0RB1
- ExchangeLSE
- CountrySpain
- CurrencyEUR
- P/E40.8
- Financial periodFY2024
- RevenueEUR 338.90M
- Revenue growth7.2%
- Net incomeEUR 10.47M
- Free cash flowEUR 11.08M
Valuation Snapshot
P/E is 40.8.
Peer valuation comparison
Latest P/E is 40.76x versus a Spain median of 15.76x (158.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 338.90M | EUR 10.47M | EUR 11.08M | n/a | 0.13 | EUR 10.49M | n/a | EUR 213.97M |
| FY2023 | EUR 316.09M | EUR 9.40M | EUR 6.65M | n/a | 0.12 | EUR 5.53M | n/a | EUR 204.35M |
| FY2022 | EUR 271.15M | EUR 8.11M | EUR 5.20M | n/a | 0.1 | EUR 6.45M | n/a | EUR 194.55M |
| FY2021 | EUR 236.23M | EUR 5.08M | -EUR 4.73M | n/a | 0.07 | EUR 5.07M | n/a | EUR 188.51M |
| FY2020 | EUR 230.08M | EUR 5.67M | EUR 6.83M | n/a | 0.07 | EUR 11.59M | n/a | EUR 184.48M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-26 | n/a | 40.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Laboratorio Reig Jofre S.A.
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health;
Related stock research
Other related stocks
Frequently asked questions
What is Laboratorio Reig Jofre S.A.'s P/E ratio?
Laboratorio Reig Jofre S.A.'s price-to-earnings (P/E) ratio is 40.8.
What does Laboratorio Reig Jofre S.A. do?
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand.